WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011159491) CONTROLLED RELEASE LEVETIRACETAM FORMULATIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/159491    International Application No.:    PCT/US2011/039030
Publication Date: 22.12.2011 International Filing Date: 03.06.2011
IPC:
A61K 9/20 (2006.01), A61K 9/28 (2006.01), A61K 31/4015 (2006.01)
Applicants: MYLAN INC. [US/US]; 1500 Corporate Drive, Suite 400 Canonsburg, PA 15317 (US) (For All Designated States Except US).
MURTY, Mummini, Aruna [IN/US]; (US) (For US Only).
LI, Boyong [US/US]; (US) (For US Only)
Inventors: MURTY, Mummini, Aruna; (US).
LI, Boyong; (US)
Agent: KRUMHOLZ, Arnold H.; Lerner, David, Littenberg, Krumholz & Mentlik, LLP 600 South Avenue West Westfield, NJ 07090 (US)
Priority Data:
12/816,620 16.06.2010 US
Title (EN) CONTROLLED RELEASE LEVETIRACETAM FORMULATIONS
(FR) FORMULATIONS DE LÉVÉTIRACÉTAM À LIBÉRATION CONTRÔLÉE
Abstract: front page image
(EN)Pharmaceutical compositions in the form of tablets are disclosed including water-soluble active ingredients such as levetiracetam and a polymer component which primarily includes water-insoluble polymers comprising between 60% and 100% of the polymer component in the tablet core, preferably the entire polymer component in the tablet core. The pharmaceutical compositions can also include an extended-release coating including both water-soluble and water-insoluble polymers.
(FR)La présente invention concerne des compositions pharmaceutiques sous la forme de comprimés comprenant des substances actives hydrosolubles telles que le lévétiracétam et un composant polymère qui comprend principalement des polymères hydrosolubles comprenant entre 60 % et 100 % du composant polymère dans le noyau de comprimé, de préférence le composant polymère total dans le noyau de comprimé. Les compositions pharmaceutiques peuvent comprendre en outre un enrobage à libération contrôlée comprenant à la fois des polymères hydrosolubles et insolubles dans l'eau.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)